New Proposal of type 3 neovascularization
Read original article here : https://www.ncbi.nlm.nih.gov/pubmed/30550528
Brolucizumab
Brolucizumab (also known as RTH258) is a humanized single-chain antibody fragment that inhibits all isoforms of VEGF-A with a molecular weight of 26 kDa. “On a molar basis, 6 mg…
Photodynamic Therapy ( PDT ) in Central Serous Chorioretinopathy (CSC)
PDT first requires the intravenous administration of a photosensitizer, followed by the administration of nonthermal red light into the affected eye. After light is absorbed by the photosensitizer, it is…
